Additionally, the oncogenic PML-RARα fusion protein is also stabilized in an USP22- and K394-mediated manner, through which USP22 defines sensitivity towards ATRA-mediated APL differentiation. The gene discussed is USP22; the disease is acute promyelocytic leukemia.